Faron leading the way in macrophage guided immunotherapy

Project description

An innovative treatment that breaks immune tolerance in cancer

Field of science

• /medical and health sciences/basic medicine/immunology/immunotherapy
• /medical and health sciences/clinical medicine/cancer
• /social sciences/economics and business/business and management/commerce

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

FARON PHARMACEUTICALS OY

Address

Joukahaisenkatu 6
20520 Turku
Finland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 2 500 000